Telo Genomics Corp
Telo Genomics Corp., a molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions, primarily in Canada. The company's TeloView platform measures the 3D structure and spatial organization of telomeres to inform on genetic and molecular characteristics that are predictive o… Read more
Telo Genomics Corp (TDSGF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 11.261x
Based on the latest financial reports, Telo Genomics Corp (TDSGF) has a cash flow conversion efficiency ratio of 11.261x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-300.71K) by net assets ($-26.70K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Telo Genomics Corp - Cash Flow Conversion Efficiency Trend (2015–2025)
This chart illustrates how Telo Genomics Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Telo Genomics Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Telo Genomics Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
TSA
KLSE:0297
|
-0.031x |
|
Moving iMage Technologies Inc
NYSE MKT:MITQ
|
0.523x |
|
Athabasca Minerals Inc
V:ABM
|
-0.001x |
|
Auga Group AB
STU:W9Z
|
0.032x |
|
Sow Good Inc. Common Stock
OTCQB:SOWG
|
-0.018x |
|
Lion Financial Group Limited
NASDAQ:LGHLW
|
-0.504x |
|
Vow Green Metals AS
OL:VGM
|
-0.030x |
|
ELEVATION GOLD MIN. CORP.
F:54NA
|
N/A |
Annual Cash Flow Conversion Efficiency for Telo Genomics Corp (2015–2025)
The table below shows the annual cash flow conversion efficiency of Telo Genomics Corp from 2015 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | $514.98K | $-2.33 Million | -4.522x | -8.50% |
| 2024-06-30 | $590.06K | $-2.46 Million | -4.168x | -314.10% |
| 2023-06-30 | $2.61 Million | $-2.63 Million | -1.006x | -45.96% |
| 2022-06-30 | $2.60 Million | $-1.79 Million | -0.690x | -130.08% |
| 2021-06-30 | $3.69 Million | $-1.10 Million | -0.300x | +79.25% |
| 2020-06-30 | $775.25K | $-1.12 Million | -1.444x | -560.26% |
| 2019-06-30 | $-1.04 Million | $-327.84K | 0.314x | -96.93% |
| 2018-06-30 | $-314.02K | $-3.21 Million | 10.211x | +387.79% |
| 2017-06-30 | $2.23 Million | $-7.90 Million | -3.548x | -186.60% |
| 2016-06-30 | $-204.85K | $-839.31K | 4.097x | +1135.19% |
| 2015-06-30 | $297.17K | $98.57K | 0.332x | -- |